DICE Therapeutics, Inc.
DICE · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $2,198 | $1,352 | $1,417 | $760 |
| - Cash | $73 | $102 | $461 | $48 |
| + Debt | $13 | $13 | $13 | $14 |
| Enterprise Value | $2,137 | $1,263 | $969 | $725 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$34 | -$26 | -$19 | -$20 |
| % Margin | – | – | – | – |
| Net Income | -$35 | -$20 | -$23 | -$20 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.74 | -0.42 | -0.5 | -0.53 |
| % Growth | -76.2% | 16% | 5.7% | – |
| Operating Cash Flow | -$29 | -$22 | -$18 | -$15 |
| Capital Expenditures | -$2 | -$0 | -$0 | -$1 |
| Free Cash Flow | -$30 | -$23 | -$18 | -$16 |